Related Experiment Videos
DNA methylation in cancer and ageing
1Department of Molecular Oncology, Graduate School of Medicine and Dentistry, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. yuasa.monc@tmd.ac.jp
Mechanisms of Ageing and Development
|December 10, 2002
Summary
Epigenetic gene silencing via DNA methylation is crucial in cancer development. Age-related methylation in normal tissues suggests potential new cancer biomarkers and therapies.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Epigenetic gene silencing, specifically DNA methylation, is increasingly recognized as a key mechanism in tumorigenesis.
- Aberrant DNA methylation patterns are observed to accumulate in normal tissues, such as the colon, with advancing age.
Purpose of the Study:
- To explore the role of age-related DNA methylation in normal tissues concerning cancer development.
- To investigate the potential of methylation changes as biomarkers for cancer and as targets for novel therapeutic strategies.
Main Methods:
- Analysis of DNA methylation patterns in normal tissues.
- Correlation of methylation changes with age.
- Investigation of methylation's link to tumorigenesis.
Main Results:
- DNA methylation increases in several genes within normal tissues with age.
- This age-related methylation is implicated in the mechanisms of cancer development.
Conclusions:
- Age-related DNA methylation in normal tissues is a significant factor in cancer initiation.
- These findings may pave the way for developing new cancer biomarkers and therapeutic approaches.